Alzheimer disease and stroke: Cognitive and neuroimaging predictors of AD and stroke

Nature Reviews Neurology

Volumn 9, Issue 11, 2013, Pages 605-606

  Ballard, Clive ^a   O'Sullivan, Michael J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTERIAL WALL THICKNESS; ARTICLE; BRAIN RADIOGRAPHY; BRAIN SIZE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; EXECUTIVE FUNCTION; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VERBAL MEMORY; VISUAL MEMORY; WHITE MATTER LESION;

ALZHEIMER DISEASE; BRAIN; COGNITION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; STROKE;

EID: 84887219350     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.215     Document Type: Article

References (8)

1. Ballard, C. et al. Alzheimer's disease. Lancet 377, 1019-1031 (2011).
2. World Health Organization. Neurological Disorders: Public Health Challenges Ch. 2 (World Health Organization Press, 2006).
3. Weinstein, G. et al. Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study. Stroke 44, 2787-2794 (2013).
4. Debette, S. et al. Association of MRI markers of vascular brain injury with incident stroke, mild cogni tive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 41, 600-606 (2010).
5. Wiberg, B. et al. Cognitive function and risk of stroke in elderly men. Neurology 74, 379-385 (2010).
6. Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207-216 (2013).
7. Johns, E. K. et al. The profile of executive functioning in amnestic mild cognitive impairment: disproportionate deficits in inhibitory control. J. Int. Neuropsychol. Soc. 18, 541-555 (2012).
8. O'Sullivan, M., Morris, R. G. & Markus, H. S. Brief cognitive assessment for patients with cerebral small vessel disease. J. Neurol. Neurosurg. Psychiatry 76, 1140-1145 (2005).